Page last updated: 2024-08-24

sodium phytate and Cardiomyopathies, Primary

sodium phytate has been researched along with Cardiomyopathies, Primary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campistol, JM; Canals, AZ; Ferrer, MD; Joubert, PH; Maduell, F; Ojeda, R; Perelló, J; Salcedo, C; Torregrosa, V1

Trials

1 trial(s) available for sodium phytate and Cardiomyopathies, Primary

ArticleYear
A phase 1b randomized, placebo-controlled clinical trial with SNF472 in haemodialysis patients.
    British journal of clinical pharmacology, 2019, Volume: 85, Issue:4

    Topics: Aged; Calcinosis; Cardiomyopathies; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Durapatite; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phytic Acid; Placebos; Renal Dialysis

2019